A previous study also reported that Pfn1 binds to PTEN (an antagonist of PI3K signaling) and that Pfn1’s interaction protects PTEN from ubiquitination, leading to an increased cellular abundance of PTEN in MDA-231 breast cancer cells when Pfn1 is stably overexpressed (52). This evidence concerns the gene PFN1 and breast carcinoma.